NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Saphetor

Saphetor

Private
LausanneHealthcare & Life Scienceshttps://www.saphetor.com/

Last Round

Seed

Feb 18, 2016

Total Funding Raised

$1.21M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Saphetor is a precision medicine company that develops bioinformatics tools and platforms for genomic data analysis, including the VarSome suite for processing and annotating Next-Generation Sequencing (NGS) data.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Healthcare Analytics, Biotechnology, Vertical SaaS

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS, Freemium

AI Layer

Application

Keywords

bioinformaticsgenomic variant interpretationclinical diagnosticsgenomic data analysisvariant annotationdiagnostic decision supportgenomicsprecision medicinegenomic data integrationbioinformatics platformAPIclinical geneticsgenomic variant classificationclinical decision supportgenomics softwareclinical bioinformaticsgenomic pipelineclinical genomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Saphetor Comps

Public and private peers based on sector, stage, and business model.

Saphetor comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Saphetor Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 18, 2016

Key People

Founding team and executive leadership

Andreas Massouras

CEO - Founder

Founding Team

Saphetor Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 8, 2026

    Bioinformatic tools cited in over 6,000 scientific papers.

  • Mar 8, 2026

    VarSome suite now has over 60,000 registered professional users.

Saphetor Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Saphetor Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Saphetor's valuation, stock price, and market status.

Firmographic Details

HeadquartersLausanne
Employee Range70
Year Founded2014
Last FundingFeb 18, 2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.